Business Context and Reporting Period
Company: Lightwave Logic, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 15, 2015
Event: Completion of a private placement offering of equity securities to accredited investors.
Key Financial Metrics and Transaction Details
- Total Proceeds: $2,015,000
- Units Sold: 20.15 Units
- Price per Unit: $100,000 (approximately $0.68 per share of Common Stock)
- Common Stock Issued: 2,963,259 shares
- Warrants Issued: 2,963,259 warrants
- Warrant Terms: Each unit includes warrants to purchase 73,530 shares at $0.85 and 73,530 shares at $1.02; expiration is 5 years from the subscription date.
- Share Count Impact: Outstanding shares increased from 58,405,704 to 61,368,963 (a 5.07% increase).
- Use of Proceeds: 60% for research and development; 40% for working capital.
Material Changes Versus Prior Period
This filing reports a discrete capital raise event rather than a periodic financial performance update. Consequently, the filing text does not provide comparative revenue, profit, cash flow, or margin data versus prior periods. The primary material change is the increase in outstanding share count and the injection of $2,015,000 in liquidity.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to allocate the majority of proceeds (60%) toward research and development, indicating a focus on product or technology advancement.
- Registration Rights: The Company is obligated to file a registration statement with the SEC within 60 calendar days of the Closing Date to register the Common Stock and underlying warrant shares.
- Unusual Items: The offering was conducted directly by the Company without the engagement of an underwriter or placement agent.
- Risks/Contingencies: The filing notes that the description of the offering is qualified by reference to the subscription agreement and warrant form attached as exhibits.
Investor Verification Checklist
- Verify the final share count and dilution impact on existing shareholders (5.07% dilution).
- Confirm the filing of the registration statement within the required 60-day window.
- Review the specific terms in the Subscription Agreement (Exhibit 10.1) and Warrant (Exhibit 10.2) for any additional covenants or restrictions.
- Monitor the allocation of funds to ensure adherence to the stated 60/40 split between R&D and working capital.